Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05161468 · ClinicalTrials.gov registry record · Phase 4
Platelet-rich Plasma, Corticosteroid, or Lidocaine for Acromioclavicular Joint Pain
A Phase 4 study, sponsored by Brooke Army Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
NCT05161468 is a Phase 4 study that was terminated before completion, run by Brooke Army Medical Center. The registered enrollment target is 34 participants.
The verdict
NCT05161468, a Phase 4 study, was terminated before completion, sponsored by Brooke Army Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
Study Summary
This study will compare three different treatment injections for the management of acromioclavicular joint dysfunction (ACJ Dysfunction). Patients that consent and enroll will be randomized to receive (1) a corticosteroid injection, (2) an injection of Platelet Rich Plasma, or (3) a Lidocaine injection. Follow-up will occur over a 1 year period.
Interventions
- DRUG Corticosteroid Injection
- DRUG Lidocaine injection
- DRUG Protein Rich Plasma(PRP) Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2021-08-12 |
| Est. Completion | 2025-05-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05161468
The ClinicalTrials.gov registry entry for NCT05161468 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brooke Army Medical Center, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Corticosteroid Injection is the first listed.
NCT05161468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05161468 about?
NCT05161468 is a clinical study titled "Platelet-rich Plasma, Corticosteroid, or Lidocaine for Acromioclavicular Joint Pain". This study will compare three different treatment injections for the management of acromioclavicular joint dysfunction (ACJ Dysfunction). Patients that consent and enroll will be randomized to receive (1) a corticosteroid injection, (2) an injection of Platelet Rich Plasma, or (3) a Lidocaine inject...
What is the current status of trial NCT05161468?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2021-08-12. Estimated completion is 2025-05-12.
What interventions are being tested in trial NCT05161468?
The interventions under investigation include: Corticosteroid Injection (DRUG), Lidocaine injection (DRUG), Protein Rich Plasma(PRP) Injection (DRUG).
Who is sponsoring clinical trial NCT05161468?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.